Anti-Ctip1/BCL-11A 抗体 [EPR14943-44]
Anti-Ctip1/BCL-11A antibody [EPR14943-44]
- Advanced Validation
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- 詳細を見る
Be the first to review this product! Submit a review
|
(12 Publications)
Anti-Ctip1/BCL-11A antibody [EPR14943-44] (ab191401) is a rabbit monoclonal antibody detecting Ctip1/BCL-11A in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF, ChIC/CUT&RUN sequencing. Suitable for Human, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
別名を表示する
CTIP1, EVI9, KIAA1809, ZNF856, BCL11A, BCL11 transcription factor A, B-cell CLL/lymphoma 11A, B-cell lymphoma/leukemia 11A, COUP-TF-interacting protein 1, Ecotropic viral integration site 9 protein homolog, Zinc finger protein 856, BCL-11A, EVI-9
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
Immunohistochemical analysis of paraffin-embedded, Human tonsil tissue labeling Ctip1/BCL-11A with ab191401 at a 1/100 dilution (19 μg/ml). Counter stained with hematoxylin. In the negative control PBS was used instead of primary antibody.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
Intracellular Flow Cytometry analysis of Jurkat (human acute T cell leukemia) labelling Ctip1/BCL-11A with purified ab191401 at 1/200 (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Alexa Fluor® 488 goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- IP
Unknown
Immunoprecipitation - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
ab191401 (purified) at 1/500 dilution (2.1 © : g/ml) immunoprecipitating Ctip1 / BCL-11A in Raji whole cell lysate.
Lane 1 (input) : Raji(Human Burkitt's lymphoma B lymphocyte) whole cell lysate 10© : g
Lane 2 (+) : ab191401 & Raji whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab191401 in Raji whole cell lysate
For western blotting, VeriBlot for IP secondary antibody (HRP) (ab131366) was used as the secondary antibody at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM /TBST .
All lanes:
Immunoprecipitation - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (ab191401)
Predicted band size: 91 kDa
false
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
Immunofluorescence analysis of, paraformaldehyde-fixed, rat C6 cells labeling Ctip1/BCL-11A with ab191401 at a 1/450 dilution (4 ug/ml). As secondary antibody goat anti-rabbit IgG (Alexa Fluor®488) ab150077 was used at a 1/200 dilution. In blue DAPI staining. In the negative controls cells were treated with anti-BCL11A at a 1/450 dilution as primary antibody and goat anti-mouse IgG (Alexa Fluor®594) at a 1/400 dilution as secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
Immunohistochemical analysis of paraffin-embedded, rat spleen tissue labeling Ctip1/BCL-11A with ab191401 at a 1/100 dilution (19 μg/ml). Counter stained with hematoxylin. In the negative control PBS was used instead of primary antibody.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : Empty
Lane 3 : BCL11A (Ctip1) knockout HAP1 whole cell lysate (20 μg)
Lane 4 : Raji whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab191401 observed at 91 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab191401 was shown to recognize BCL11A (Ctip1) in wild type cells as signal was lost at the expected MW in BCL11A (Ctip1) knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and BCL11A (Ctip1) knockout samples were subjected to SDS-PAGE. ab191401 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (ab191401)
Predicted band size: 91 kDa
false
- WB
Supplier Data
Western blot - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
All lanes:
Western blot - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (ab191401) at 1/50000 dilution
All lanes:
293 cell lysate at 10 µg
Secondary
All lanes:
goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Predicted band size: 91 kDa
Observed band size: 120 kDa
true
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 Raji (human Burkitt's lymphoma B lymphocyte) cells and 5 µg of ab191401 [EPR14943-44]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 Raji (human Burkitt's lymphoma B lymphocyte) cells and 5 µg of ab191401 [EPR14943-44]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 Raji (human Burkitt's lymphoma B lymphocyte) cells and 5 µg of ab191401 [EPR14943-44]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Supplier Data
Western blot - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (AB191401)
All lanes:
Western blot - Anti-Ctip1/BCL-11A antibody [EPR14943-44] (ab191401) at 1/50000 dilution
Lane 1:
Raji cell lysate at 20 µg
Lane 2:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Predicted band size: 91 kDa
Observed band size: 120 kDa
true
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-Ctip1/BCL-11A antibody [EPR14943-44] - BSA and Azide free
Reactivity data
製品の詳細
What is this antibody validated in?
Anti-Ctip1/BCL-11A antibody [EPR14943-44] (ab191401) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) and ChIC/CUT&RUN sequencing in Human, Rat samples.
What is the molecular weight of Ctip1/BCL-11A?
Anti-Ctip1/BCL-11A [EPR14943-44] (ab191401) specifically detects a band for Ctip1/BCL-11A (UniProt: Q9H165) at a molecular weight of 91kDa.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-Ctip1/BCL-11A antibody [EPR14943-44] (ab191401) has been confirmed by Western blot testing in BCL11A Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR14943-44] also available for your convenience: ab191401, Carrier free - ab242406
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (12)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:30552 PubMed40836054
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6919 PubMed40715076
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 44:3448-3467 PubMed40328966
2025
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 15:e17810 PubMed37807875
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 24:2235768 PubMed37548553
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed36230873
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell chemical biology 29:1273-1287.e8 PubMed35839780
2022
Applications
Unspecified application
Species
Unspecified reactive species
eLife 10: PubMed34585664
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature genetics 53:511-520 PubMed33649594
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 19:2916-2924 PubMed32218847
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com